Your browser doesn't support javascript.
loading
Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
Andoh, Kiyohiko; Yamazaki, Kenichi; Honda, Yoko; Honda, Takashi.
Affiliation
  • Andoh K; Animal Pharmaceuticals Division, The Chemo-Sero-Therapeutic Research Institute, 1-6-1 Okubo, Kita-ku, Kumamoto, Kumamoto, 860-8568, Japan. andou-ki@kaketsuken.or.jp.
  • Yamazaki K; Animal Pharmaceuticals Division, The Chemo-Sero-Therapeutic Research Institute, 1-6-1 Okubo, Kita-ku, Kumamoto, Kumamoto, 860-8568, Japan.
  • Honda Y; Animal Pharmaceuticals Division, The Chemo-Sero-Therapeutic Research Institute, 1-6-1 Okubo, Kita-ku, Kumamoto, Kumamoto, 860-8568, Japan.
  • Honda T; Animal Pharmaceuticals Division, The Chemo-Sero-Therapeutic Research Institute, 1-6-1 Okubo, Kita-ku, Kumamoto, Kumamoto, 860-8568, Japan.
Arch Virol ; 162(4): 931-941, 2017 Apr.
Article in En | MEDLINE | ID: mdl-27942974
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poultry Diseases / Viral Proteins / Viral Vaccines / Marek Disease / Herpesvirus 1, Meleagrid / Antibodies, Viral Limits: Animals Language: En Journal: Arch Virol Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poultry Diseases / Viral Proteins / Viral Vaccines / Marek Disease / Herpesvirus 1, Meleagrid / Antibodies, Viral Limits: Animals Language: En Journal: Arch Virol Year: 2017 Document type: Article Affiliation country: